The Utility of Data Tokenization in Clinical Trials

With the growing rate of real-world data (RWD) sources and the evolution of data technologies, it is essential to understand the advantages and challenges tied to linked RWD. In a study conducted by Boehringer Ingelheim and Science 37, they showed nearly 90% overlap between trial patient cohort and real-world datasets, even with small trial populations.

Learn how tokenization enables:

  • Connecting diverse data sources to your clinical trials
  • Protecting personally identifiable information
  • Earlier access to real-world data

See how Datavant can link data directly into clinical trials, providing the potential to validate real world populations prior to marketing authorization.

Achieve your boldest ambitions

Explore how Datavant can be your health data logistics partner.

Contact us